<DOC>
	<DOC>NCT01575834</DOC>
	<brief_summary>The purpose of this study is to determine if treatment is effective in preventing fractures in women with postmenopausal osteoporosis</brief_summary>
	<brief_title>Registrational Study With AMG 785 to Treat Postmenopausal Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis, Postmenopausal</mesh_term>
	<mesh_term>Denosumab</mesh_term>
	<criteria>Postmenopausal women osteoporosis, defined as low bone mineral density Severe osteoporosis Use of agents affecting bone metabolism History of metabolic or bone disease (except osteoporosis) Vitamin D insufficiency (vitamin D repletion and rescreening is permitted) Current hyper or hypocalcemia Current, uncontrolled hyper or hypothyroidism Current, uncontrolled hyper or hypoparathyroidism</criteria>
	<gender>Female</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Osteoporosis, Osteoporosis-Postmenopausal, Bone Diseases-Metabolic, Bone Diseases, Musculoskeletal Diseases</keyword>
</DOC>